William J. Newell
2020
In 2020, William J. Newell earned a total compensation of $2.2M as Chief Executive Officer at SUTRO BIOPHARMA, a 44% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $318,550 |
|---|---|
| Option Awards | $707,500 |
| Salary | $554,000 |
| Stock Awards | $554,950 |
| Other | $20,502 |
| Total | $2,155,502 |
Newell received $707.5K in option awards, accounting for 33% of the total pay in 2020.
Newell also received $318.6K in non-equity incentive plan, $554K in salary, $555K in stock awards and $20.5K in other compensation.
Rankings
In 2020, William J. Newell's compensation ranked 5,190th out of 13,090 executives tracked by ExecPay. In other words, Newell earned more than 60.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,190 out of 13,090 | 60th |
Division Manufacturing | 2,131 out of 5,621 | 62nd |
Major group Chemicals And Allied Products | 851 out of 2,254 | 62nd |
Industry group Drugs | 733 out of 1,954 | 63rd |
Industry Biological Products, Except Diagnostic Substances | 175 out of 411 | 57th |
Source: SEC filing on April 29, 2021.
Newell's colleagues
We found three more compensation records of executives who worked with William J. Newell at SUTRO BIOPHARMA in 2020.
News
SUTRO BIOPHARMA CEO William Newell's 2021 pay jumps 161% to $5.6M
April 22, 2022
SUTRO BIOPHARMA CEO William Newell's 2020 pay falls 44% to $2.2M
April 29, 2021
SUTRO BIOPHARMA CEO William Newell's 2019 pay falls 56% to $3.8M
April 24, 2020
SUTRO BIOPHARMA CEO William Newell's 2018 pay jumps 1,136% to $8.7M
April 25, 2019